Centro para el Desarrollo de la Investigación Científica, Asunción, Paraguay.
Centro de Especialidades Dermatológicas - Programa Nacional de Control de la Lepra, San Lorenzo, Paraguay.
Am J Trop Med Hyg. 2019 Oct;101(4):780-788. doi: 10.4269/ajtmh.18-0880.
American tegumentary leishmaniasis is an endemic anthropozoonosis undergoing expansion on the American continent. The disease is caused by several species and it is manifested as cutaneous and mucocutaneous leishmaniasis. In this study, we evaluate the viability of high-resolution melt polymerase chain reaction (HRM-PCR) analysis to differentiate four closely related species as a routine tool for the diagnosis of leishmaniasis. For this purpose, biopsy specimens from cutaneous and mucocutaneous lesions were taken from 132 individuals from endemic and non-endemic areas for leishmaniasis. Each sample was processed for parasitological, histopathological, and molecular analysis. Positive biopsy samples were analyzed by HRM-PCR of a 144-bp heat-shock protein (hsp70) gene fragment, and new cases were confirmed by sequencing. Of the 132 samples analyzed, 36 (27%) were positive for spp., of which 86% were from cutaneous lesions and 14% from mucocutaneous lesions. We identified () (84%), () (13%), and () (3%) in cutaneous lesions, and () (40%), () (20%), () (20%), and () (20%) in mucocutaneous lesions. The main purpose of this research was to report for the first time in Paraguay the presence of () and () in patients with cutaneous and mucocutaneous lesions, using the HRM-PCR technique. In addition, we report the presence of additional new cases of () in cutaneous lesions.
美洲皮肤利什曼病是一种在美洲大陆呈扩张态势的地方性人兽共患传染病。该病由几种密切相关的物种引起,表现为皮肤利什曼病和黏膜皮肤利什曼病。在这项研究中,我们评估了高分辨率熔解聚合酶链反应(HRM-PCR)分析区分四个密切相关物种的可行性,将其作为利什曼病诊断的常规工具。为此,我们从利什曼病流行和非流行地区的 132 名个体的皮肤和黏膜病变活检标本中进行了寄生虫学、组织病理学和分子分析。对寄生虫学阳性的活检样本进行了 144bp 热休克蛋白(hsp70)基因片段的 HRM-PCR 分析,并通过测序对新病例进行了确认。在分析的 132 个样本中,有 36 个(27%)为 spp.阳性,其中 86%来自皮肤病变,14%来自黏膜皮肤病变。我们在皮肤病变中鉴定出了 () (84%)、 () (13%)和 () (3%),在黏膜皮肤病变中鉴定出了 () (40%)、 () (20%)、 () (20%)和 () (20%)。本研究的主要目的是首次在巴拉圭报告了 HRM-PCR 技术在皮肤和黏膜病变患者中存在 () 和 () 。此外,我们还报告了在皮肤病变中存在额外的 () 新病例。